EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC 4.0

Obesity increases allergic airway inflammation that can be successfully treated by oral tolerance

Nora Geissler iD, Maria Orola, Masoumeh Alinaghi iD, Alexander Nardo iD, Thomas M Stulnig iD, Joana Séneca iD, Anna Schmid iD, Elke Korb, Tatjana Svoboda, Erika Garner-Spitzer iD, Michael Kundi iD, Monika Ehling-Schulz iD und 3 weitere

Allergy · 2024

DOI: 10.1111/all.15989 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Allergy, 2024. Verfasst von Nora Geissler und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienn…. Hauptthemen laut MEDLINE: Inflammation, Respiratory System. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The Austrian Science Fund (FWF), Government of Lower Austria (Land Niederösterreich), Danube-Allergy Research Cluster.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral treatment with OVA does not affect the microbiota composition but maintains M1 polarized macrophages in obese C57BL/6 mice.Level of β-hexosaminidase released by RBL cells incubated with (A) BAL, and (B) serum samples.(C) The OVA-specific IL-5 and, (D) the OVA-specific IL-13 in OVA-stimulated lung supernatant.(E) The absolute number of eosinophils in the lung (F) H&E-stained and PAS-stained lung sections from one representative sample from each group.(G) Inflammation lung scores.The absolute number of (H) B cells, (I) T cells, and (J) Tregs in the lung.(K) PCA score plots for all experimental samples, colored based on the treatment (red: HFD/ Allergy, dark green: HFD/OT, blue: HFD/PBS, orange: STD/Allergy, light green: STD/OT, purple: STD/PBS).(L) Alpha-and (M) beta diversity plots are depicted per treatment.One representative example from lung sections stained with anti-F4/80 + anti-iNOS antibodies and anti-F4/80 + anti-CD206 antibodies in (N) obese and (O) lean mice from allergic, OT and PBS groups.(P) The percentage of M1 and M2macrophages in the lungs of obese and lean allergic, OT, and PBS-treated mice was analyzed by TissueQuest Software after acquiring images on a TissueFaxs microscope.Test results with a p-value below 0.05 were considered significant.For illustrative purposes, p-values were indicated as: *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p < 0.0001.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InflammationRespiratory SystemHumansAnimalsMiceObesityDisease Models, AnimalMice, Inbred BALB CLung

Autor:innen und Institutionen

  • Institute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
  • Functional Microbiology, Institute of Microbiology, Department of Pathobiology, University of Veterinary Medicine, Vienna, Austria.
  • Clinical Division of Endocrinology & Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
  • Department of Medicine III and Karl Landsteiner Institute for Metabolic Diseases and Nephrology, Clinic Hietzing, Vienna, Austria.
  • Joint Microbiome Facility of the Medical University of Vienna and the University of Vienna, Vienna, Austria.
  • Department of Microbiology and Ecosystem Science, Centre for Microbiology and Environmental Systems Science, University of Vienna, Vienna, Austria.

ORCID-Profile: Nora Geissler, Masoumeh Alinaghi, Alexander Nardo, Thomas M Stulnig, Joana Séneca, Anna Schmid, Erika Garner-Spitzer, Michael Kundi, Monika Ehling-Schulz, Irma Schabussova, Aleksandra Inic-Kanada, Ursula Wiedermann

Förderung

  • The Austrian Science Fund (FWF)
  • Government of Lower Austria (Land Niederösterreich)
  • Danube-Allergy Research Cluster
  • PhD Program Molecular, Cellular and Clinical Allergology (MCCA)
  • Austrian Science Fund

Zitieren

APA

Geissler, N., Orola, M., Alinaghi, M., Nardo, A., Stulnig, T. M., Séneca, J., Schmid, A., Korb, E., Svoboda, T., Garner-Spitzer, E., Kundi, M., Ehling-Schulz, M., Schabussova, I., Inic-Kanada, A., & Wiedermann, U. (2024). Obesity increases allergic airway inflammation that can be successfully treated by oral tolerance. Allergy. https://doi.org/10.1111/all.15989

Vancouver

Geissler N, Orola M, Alinaghi M, Nardo A, Stulnig TM, Séneca J, et al. Obesity increases allergic airway inflammation that can be successfully treated by oral tolerance. Allergy. 2024. doi:10.1111/all.15989

BibTeX
@article{Geissler2024,
  author = {Geissler, Nora and Orola, Maria and Alinaghi, Masoumeh and Nardo, Alexander and Stulnig, Thomas M and Séneca, Joana and Schmid, Anna and Korb, Elke and Svoboda, Tatjana and Garner-Spitzer, Erika and Kundi, Michael and Ehling-Schulz, Monika and Schabussova, Irma and Inic-Kanada, Aleksandra and Wiedermann, Ursula},
  title = {Obesity increases allergic airway inflammation that can be successfully treated by oral tolerance},
  journal = {Allergy},
  year = {2024},
  doi = {10.1111/all.15989}
}
Kostenlos starten →